- Monographs -

Effective Approaches to Standardization and Implementation of Smart Pump Technology

Program Description In 2006, the Institute of Medicine (IOM) investigated all aspects of medication safety, including the impact of technology in adverting some of the 1.5 million preventable adverse drug events that occur in US hospitals each year. Recommendations from this investigation included the widespread adoption of information technology by healthcare facilities. This program addresses the IOM report, the current use and role of smart pumps, and the planning process needed for smart pump implementation.

Learning Objectives

Upon completion of this activity, pharmacists and nurses will be able to:

• Describe the recommendations of the 2006 Institute of Medicine (IOM) report on preventing

• medication errors that relate to infusion therapy and "smart" pump technology.

• Discuss the current state of smart pump use in U.S. hospitals.

• Understand the role of smart pump technology in preventing medication errors.

• Create a plan for smart pump implementation, including defining scope of use, development of drug libraries, providing education, and conducting maintenance and monitoring.

Program Faculty

Michael R. Cohen, RPh, MS, ScD, FASHP
President
Institute for Safe Medication Practices (ISMP)
Huntingdon Valley, PA

Philip Schneider, MS, FASHP
Clinical Professor
Director of the Latiolais Leadership Program,
Division of Pharmacy Practice and Administration
The Ohio State University
Columbus, OH

Kristin Niemi, PharmD
Pharmacy Educator
Sutter Medical Center
Sacramento, CA

CE Accreditation:

Pharmacists:
Continuing education (CE) credit will be provided by the Pediatric Pharmacy Advocacy Group (PPAG). PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. This program (180-999-07-503-H04) is approved for 1.5 contact hours (.15 CEUs) of CE credit, and is provided free of charge. Pharmacists who complete the program may take the test and print their CE certificate from the Institute for Safe Medication Practices (ISMP) website at www.ismp.org/smartpumpce.

The release date of this program is May 1, 2007 and the expiration date is May 1, 2010.

Nurses:
Debora Simmons is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program (CEP 13677) is approved for 1 contact hour (0.1 CEUs) of continuing nursing education. Nurses who complete this program may take the test and print their CE statements from the ISMP website at www.ismp.org/smartpumpce.

The release date of this program is May 1, 2007 and the expiration date is May 1, 2010.

Disclosure Statements

It is the policy of PPAG to ensure independence, balance, objectivity, and scientific rigor in all its individually or jointly presented education programs. All faculty participating in PPAG programs are expected to disclose any real or apparent conflict(s) of interest that may have a direct or indirect bearing on the subject matter of the continuing education program. Disclosure pertains to relationships with any pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related or unrelated to the subject matter of the presentation topic.